Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.10
-0.12 (-0.52%)
At close: Sep 16, 2026, 4:00 PM EDT
23.28
+0.18 (0.78%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Beam Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Beam Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $52.15. The average 1-year stock price forecast is 125.76% higher than the current stock price, while the lowest is $26 (+12.55%) and the highest is $80 (+246.32%).
Price Target: $52.15 (+125.76%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Beam Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $65 | Buy | Maintains | $65 | +181.39% | Sep 9, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $35 | Buy | Reiterates | $35 | +51.52% | Sep 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $78 | Buy | Reiterates | $78 | +237.66% | Sep 9, 2026 |
| Clear Street | Clear Street | Buy Reiterates $37 | Buy | Reiterates | $37 | +60.17% | Sep 9, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $43 | Buy | Maintains | $43 | +86.15% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
48.57M
from 139.74M
Decreased by -65.24%
Revenue Next Year
62.75M
from 48.57M
Increased by 29.19%
EPS This Year
-4.45
from -0.81
EPS Next Year
-4.74
from -4.45
EPS and Forward PE are based on non-GAAP adjusted numbers.